Department of Metabolic and Investigative Medicine, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom.
Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Surg Obes Relat Dis. 2018 Jun;14(6):857-864. doi: 10.1016/j.soard.2018.02.021. Epub 2018 Mar 6.
Although laparoscopic sleeve gastrectomy is an established operation for severe obesity, there is controversy regarding the extent to which the antrum is excised. The objective of this systematic review was to investigate the effect on perioperative complications and medium-term outcomes of antral resecting versus antral preserving sleeve gastrectomy. MEDLINE, EMBASE, and Cochrane databases were searched from 1946 to April 2017. Eligible studies compared antral resection (staple line commencing 2-3 cm from pylorus) with antral preservation (>5 cm from pylorus) in patients undergoing primary sleeve gastrectomy for obesity. Meta-analyses were performed with a random-effects model, and risk of bias within and across studies was assessed using validated scoring systems. Eight studies (619 participants) were included: 6 randomized controlled trials and 2 cohort studies. Overall follow-up was 94% for the specified outcomes of each study. Mean percentage excess weight loss was 62% at 12 months (7 studies; 574 patients) and 67% at 24 months (4 studies; 412 patients). Antral resection was associated with significant improvement in percentage excess weight loss at 24-month follow-up (mean 70% versus 61%; standardized mean difference .95; confidence interval .35-1.58, P<.005), an effect that remained significant when cohort studies were excluded. There was no difference in incidence of perioperative bleeding, leak, or de novo gastroesophageal reflux disease. According to the available evidence, antral resection is associated with better medium-term weight loss compared with antral preservation, without increased risk of surgical complications. Further randomized clinical trials are indicated to confirm this finding.
虽然腹腔镜袖状胃切除术是治疗重度肥胖的一种成熟手术,但对于胃窦切除的范围仍存在争议。本系统评价的目的是调查胃窦切除与胃窦保留袖状胃切除术对围手术期并发症和中期结果的影响。从 1946 年到 2017 年 4 月,我们检索了 MEDLINE、EMBASE 和 Cochrane 数据库。合格的研究比较了在接受原发性袖状胃切除术治疗肥胖症的患者中,胃窦切除(吻合线起始于幽门 2-3cm 处)与胃窦保留(距幽门>5cm)的效果。采用随机效应模型进行荟萃分析,并使用经过验证的评分系统评估研究内和研究间的偏倚风险。共纳入 8 项研究(619 例患者):6 项随机对照试验和 2 项队列研究。每项研究指定结局的总体随访率为 94%。12 个月时的平均超重体重减轻率为 62%(7 项研究;574 例患者),24 个月时为 67%(4 项研究;412 例患者)。胃窦切除与 24 个月随访时超重体重减轻率的显著改善相关(平均 70%比 61%;标准化均数差值.95;置信区间.35-1.58,P<.005),当排除队列研究时,这种效果仍然显著。胃窦切除与胃窦保留相比,在围手术期出血、漏和新发胃食管反流病的发生率方面没有差异。根据现有证据,与胃窦保留相比,胃窦切除与更好的中期减重效果相关,且手术并发症风险没有增加。需要进一步的随机临床试验来证实这一发现。